Skip to content

Research for the efficacy of the workplace COVID-19 vaccinations

Research for the efficacy of the workplace COVID-19 vaccinations - Research of the workplace COVID-19 vaccinations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000046185
Enrollment
3000
Registered
2021-11-25
Start date
2022-01-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Faculties, staffs and students of Keio University. -Administered Moderna COVID-19 vaccine at workplace vaccination of Keio University -Written informed consent obtained and suitable for peripheral blood sample collection.

Exclusion criteria

Exclusion criteria: -Under 18 years-old -Not suitable for blood sample collection medically.

Design outcomes

Primary

MeasureTime frame
the acquisition of humoral and cellular immunity for SARS-CoV-2

Countries

Japan

Contacts

Public ContactYoshifumi Uwamino

Keio University Department of Laboratory Medicine, School of Medicine

covid-vaccine-research-group@keio.jp+81-3-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026